Neurocrine Biosciences Inc
NASDAQ:NBIX

Watchlist Manager
Neurocrine Biosciences Inc Logo
Neurocrine Biosciences Inc
NASDAQ:NBIX
Watchlist
Price: 123.89 USD -1.29% Market Closed
Market Cap: 12.5B USD
Have any thoughts about
Neurocrine Biosciences Inc?
Write Note

Neurocrine Biosciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neurocrine Biosciences Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Neurocrine Biosciences Inc
NASDAQ:NBIX
Cash from Operating Activities
$476.4m
CAGR 3-Years
12%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$16.5B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$10B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$7.3B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
-$944m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.2B
CAGR 3-Years
-11%
CAGR 5-Years
12%
CAGR 10-Years
18%

See Also

What is Neurocrine Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
476.4m USD

Based on the financial report for Sep 30, 2024, Neurocrine Biosciences Inc's Cash from Operating Activities amounts to 476.4m USD.

What is Neurocrine Biosciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
37%

Over the last year, the Cash from Operating Activities growth was 16%. The average annual Cash from Operating Activities growth rates for Neurocrine Biosciences Inc have been 12% over the past three years , 37% over the past five years .

Back to Top